Prenetics Global is trading at $25.22, up 11.07%, with the move appearing linked mainly to positive biotechnology-sector sentiment.
- XBI was up 2.61% pre-market, though Prenetics Global’s gain was substantially larger.
- No fresh company-specific announcement or earnings catalyst was identified for September 24, 2026.
- Craig-Hallum’s September 17, 2026 Buy initiation and $40 target remain supportive background but are unlikely to fully explain the move.